Osaic Holdings
DAWN

Osaic Holdings’s Day One Biopharmaceuticals DAWN Stock Holding History

Osaic Holdings’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.91K Sell
229
-39,261
-99% -$553K ﹤0.01% 6692
2025
Q4 		$368K Buy
39,490
+2,195
+6% +$18.3K ﹤0.01% 3612
2025
Q3 		$261K Buy
37,295
+4,414
+13% +$30.4K ﹤0.01% 3996
2025
Q2 		$214K Sell
32,881
-32,430
-50% -$223K ﹤0.01% 3883
2025
Q1 		$518K Buy
65,311
+32,459
+99% +$350K ﹤0.01% 2840
2024
Q4 		$416K Buy
32,852
+32,421
+7,522% +$451K ﹤0.01% 2959
2024
Q3 		$6K Buy
431
+263
+157% +$3.75K ﹤0.01% 6114
2024
Q2 		$2.31K Buy
+168
New +$2.46K ﹤0.01% 6541
2023
Q4 		– Sell
-24
Closed -$294 – 7338
2023
Q3 		$294 Buy
24
+10
+71% +$130 ﹤0.01% 7089
2023
Q2 		$167 Sell
14
-169
-92% -$2.21K ﹤0.01% 7234
2023
Q1 		$2.44K Buy
+183
New +$3.58K ﹤0.01% 6632
2022
Q3 		– Sell
-1
Closed – – 7298
2022
Q2 		$0 Buy
+1
New +$10 ﹤0.01% 7393

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Osaic Holdings's DAWN Position: Q1 2026 in Review

Osaic Holdings reduced its Day One Biopharmaceuticals (DAWN) stake by 99% in Q1 2026, selling an estimated $553K and leaving 229 shares worth $4.91K. The position accounts for ﹤0.01% of the portfolio, ranked #6692.

Osaic Holdings first reported a position in DAWN in Q2 2022 and has held it in 12 quarters since. The position peaked at $518K in Q1 2025. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Osaic Holdings held 229 shares of Day One Biopharmaceuticals worth $4.91K as of Q1 2026.
  • Osaic Holdings sold 39,261 Day One Biopharmaceuticals shares in Q1 2026, an estimated $553K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6692 holding.
  • Osaic Holdings first reported a position in Day One Biopharmaceuticals in Q2 2022 and has held it in 12 quarters since.
  • Osaic Holdings's Day One Biopharmaceuticals position peaked at $518K in Q1 2025.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.